With this enhancement in the CureMD application, the insurance code(s) field becomes mandatory for Medicare secondary insurance entries, ensuring data accuracy and compliance. This change aligns the validation rules for Medicare secondary insurance with those of Medicare tertiary insurance, enhancing consistency across the platform.
This enhancement allows the user to replace current medications in a patient's treatment plan with biosimilars preferred by their insurance. It ensures the continuity of the treatment by preserving the schedule of the previously consumed drug for the newly replaced biosimilar, while historical treatment data is updated to reflect the change.
This enhancement in the Chemotherapy Manager System has been designed to facilitate the replacement of current medications in a patient's treatment plan with those preferred by their insurance, focusing on the transition from one brand to another, brand to generic drugs, or vice versa. This system ensures that when a drug is replaced due to insurance preferences, the historical data of drug consumption is preserved, reflecting the old medication on past treatment days and the new, replaced medication on future treatment days.
This enhancement in the Chemotherapy Manager has been designed to help healthcare providers manage and adjust chemotherapy treatment plans for their patients based on the changing preferences of insurance companies regarding medication. This enables the healthcare providers to easily update chemotherapy treatment plans with insurance-preferred drugs when insurance companies change their preferred drug lists.
With this enhancement in the CureMD application, users can create MIPS reporting entities for the current performance year within the Quality Programs section, ensuring timely and accurate reporting. This enables them to qualify for incentives through precise reporting.
With this enhancement in the CureMD application, the visualization of the Key Performance Indicators (KPIs) offers a dynamic and engaging way to view practice management and performance. This enhances the clarity and accessibility of financial data, enabling users to spot trends and understand their financial health at a glance.
With this enhancement in the CureMD application, users have the ability to halt claim submissions for claims marked as ‘on hold’, ensuring no such claim is submitted until its status is updated. This reinforces the accuracy of the claim management process by preventing premature submissions.
With this enhancement in the CureMD application, the selection of the income verification source requires manual input by default, ensuring accuracy in documenting income and preventing billing issues. This promotes meticulous documentation practices by requiring a deliberate choice of verification source.
With this enhancement in the CureMD application, the ‘Practice’ field is disabled once the practice name is entered into the system. This ensures smooth functioning of the Chemotherapy Manager by eliminating errors related to the practice name changes.
With this enhancement in the CureMD application, the eligibility response screen displays overall visits quantity and overall used quantity information regarding patients. This makes it easier for users to understand insurance visit limitations clearly and manage services more efficiently.
Posted On: Feb 27, 2024
Posted On: Feb 27, 2024
Posted On: Feb 27, 2024
Posted On: Feb 27, 2024
Posted On: Feb 27, 2024
Posted On: Feb 27, 2024